ストックスクリーナーアプリを入手
5.03
6.12%
0.29
アフターアワーズ：
5.11
0.08
+1.59%
前日終値:
$4.74
開ける：
$4.76
24時間の取引高:
49,360
Relative Volume:
0.16
時価総額：
$94.07M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+5.45%
1か月 パフォーマンス:
-12.98%
6か月 パフォーマンス:
-19.78%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.71
$5.12
1週間の範囲:
$4.6017
$5.30
52週間の値動き範囲:
$2.14
$12.50
Kalaris Therapeutics Inc Stock (KLRS) Company Profile
名前
Kalaris Therapeutics Inc
セクター
電話
650-249-2727
住所
628 MIDDLEFIELD ROAD, PALO ALTO
KLRS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KLRS
Kalaris Therapeutics Inc
|
5.03 | 88.65M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kalaris Therapeutics Inc Stock (KLRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-03 | 開始されました | Raymond James | Strong Buy |
| 2025-07-23 | 再開されました | Piper Sandler | Neutral |
| 2025-05-07 | 開始されました | Leerink Partners | Outperform |
| 2025-04-08 | 開始されました | William Blair | Outperform |
Kalaris Therapeutics Inc (KLRS) 最新ニュース
Tools to assess Kalaris Therapeutics Inc.’s risk profileDollar Strength & Safe Investment Capital Preservation Plans - newser.com
Can trapped investors hope for a rebound in Kalaris Therapeutics Inc.Market Trend Summary & Stepwise Swing Trade Plans - newser.com
Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Declines By 40.5% - MarketBeat
How resilient is Kalaris Therapeutics Inc. stock in market downturnsTrade Performance Summary & Safe Swing Trade Setups - newser.com
What to expect from Kalaris Therapeutics Inc. in the next 30 daysWeekly Trend Recap & Real-Time Volume Spike Alerts - newser.com
Will Kalaris Therapeutics Inc. outperform the marketProfit Target & Risk Controlled Stock Alerts - newser.com
How Kalaris Therapeutics Inc. stock performs in rate cut cyclesWeekly Trend Report & Consistent Income Trade Ideas - newser.com
What MACD and RSI say about Kalaris Therapeutics Inc.Weekly Market Summary & Expert-Curated Trade Recommendations - newser.com
Is Kalaris Therapeutics Inc. stock positioned for digital transformationWatch List & Fast Entry Momentum Alerts - newser.com
Analyzing Kalaris Therapeutics Inc. with risk reward ratio chartsJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Can Kalaris Therapeutics Inc. rally from current levelsRecession Risk & Verified Momentum Watchlists - newser.com
How to use a screener to detect Kalaris Therapeutics Inc. breakoutsJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com
Kalaris Therapeutics Inc. stock outlook for YEAR2025 Performance Recap & Community Verified Watchlist Alerts - newser.com
Published on: 2025-10-31 05:04:53 - newser.com
Identifying reversal signals in Kalaris Therapeutics Inc.Weekly Earnings Recap & Low Risk Investment Opportunities - newser.com
Kalaris to Present at Stifel 2025 Annual Healthcare Conference - Investing News Network
Kalaris (Nasdaq: KLRS) to present at Stifel Healthcare Conference; CEO & CMO 3:20–3:50 ET - Stock Titan
Leading vs lagging indicators on Kalaris Therapeutics Inc. performance2025 AllTime Highs & Safe Capital Growth Tips - newser.com
Published on: 2025-10-30 01:28:32 - newser.com
How supply chain issues affect Kalaris Therapeutics Inc. stockJuly 2025 Reactions & Smart Allocation Stock Tips - fcp.pa.gov.br
Published on: 2025-10-28 03:17:08 - newser.com
Does Kalaris Therapeutics Inc. qualify in momentum factor screeningWeekly Risk Report & High Conviction Trade Alerts - newser.com
Kalaris Therapeutics Inc (KLRS) 財務データ
Kalaris Therapeutics Inc (KLRS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):